Novavax Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	28,651	19,659	26,836	9,640	17,241	221,759
Market Cap Growth	11.38%	-26.74%	178.39%	-44.09%	-92.22%	173.23%
Enterprise Value	20,702	10,446	13,348	3,018	5,861	191,455
Last Close Price	176.00	119.51	167.00	81.41	200.00	2936.67
PE Ratio	3.61	2.48	-	-	-	-
PS Ratio	1.42	0.97	1.89	0.58	0.45	9.44
PB Ratio	-12.46	-8.55	-2.06	-0.79	-1.39	-30.76
P/FCF Ratio	-	-	-	-	-	40.30
P/OCF Ratio	-	-	-	-	-	33.50
EV/Sales Ratio	1.06	0.52	0.94	0.18	0.15	8.15
EV/EBITDA Ratio	1.99	0.98	-	-	-	-
EV/EBIT Ratio	2.11	1.03	-	-	-	-
EV/FCF Ratio	-4.60	-	-	-	-	34.79
Debt / Equity Ratio	-2.18	-2.18	-0.42	-0.39	-0.97	-1.49
Debt / EBITDA Ratio	0.46	0.46	-	-	-	-
Debt / FCF Ratio	-	-	-	-	-	1.95
Net Debt / Equity Ratio	3.58	3.58	1.06	0.40	1.14	2.82
Net Debt / EBITDA Ratio	-0.77	-0.77	3.60	0.56	1.17	0.59
Net Debt / FCF Ratio	1.83	1.83	6.58	0.38	1.43	-3.69
Asset Turnover	0.82	0.82	0.41	0.49	0.82	0.55
Inventory Turnover	39.01	39.01	22.59	26.47	90.94	-
Quick Ratio	1.83	1.83	0.89	0.53	0.58	0.82
Current Ratio	2.13	2.13	0.98	0.70	0.69	0.90
Return on Equity (ROE)	-	-	-	-	-	-1265.71%
Return on Assets (ROA)	25.72%	25.72%	-8.63%	-17.02%	-16.67%	-50.69%
Return on Capital Employed (ROCE)	78.60%	78.60%	-57.10%	-340.10%	320.30%	-904.70%
Earnings Yield	27.67%	40.32%	-14.56%	-95.59%	-74.44%	-16.12%
FCF Yield	-15.72%	-22.91%	-7.79%	-134.64%	-57.14%	2.48%
Buyback Yield / Dilution	-13.74%	-13.74%	-51.03%	-28.89%	-5.08%	-29.27%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.